3 December 2015
3 December 2015 at 10.00am
George Hudson Boardroom, West Offices, Station Rise, York YO1 6GA
Prior to the commencement of the meeting a period of up to 20 minutes will be set aside for questions or comments from members of the public who have registered in advance their wish to participate; this will start at 10am.
For members accessing papers electronically the number of enclosures is indicated if there is more than one.
| Standing items | ||||
| 1. | Apologies for Absence | |||
| 2. | Declarations of Members’ Interests in Relation to the Business of the Meeting |
Verbal | ||
| 3. | Minutes of the Meeting held on 1 October 2015 | Enclosure | Keith Ramsay | View |
| 4. | Matters Arising from the Minutes | Verbal | All | |
| 5. | Chief Clinical Officer Report | Enclosure | Mark Hayes | View |
| 6. | Corporate Risk Update Report | Enclosure | Rachel Potts | View |
| Performance and Finance | ||||
|
7. 7.1 7.2 |
Integrated Quality and Performance Governing Body Assurance Report: Quality and Performance Assurance Data: Quarter 2 2015/16 Quality and Performance Governing Body Report |
Enclosuresx4 |
Michelle Carrington |
|
| 8. | Financial Performance Report | Enclosuresx2 | Tracey Preece Rachel Potts |
|
| Assurance | ||||
| 9. | Procurement Policy | Enclosures | Tracey Preece | View |
| 10 | Equality, Diversity and Human Rights Strategy Update |
Enclosuresx3 | Rachel Potts | |
| Received Items | ||||
| 11. 11.1 11.2 |
Quality and Finance Committee Minutes: 22 October 2015 19 November 2015 |
Enclosuresx3 | ||
| 12. 12.1 12.2 |
Medicines Commissioning Committee Minutes: 16 September 2015 21 October 2015 |
Enclosuresx3 | ||
| Next Meeting | ||||
| 13. | 10am on 4 February 2016 in the George Hudson Boardroom, West Offices, Station Rise, York YO1 6GA |
To Note | ||
| Exclusion of Press and Public | ||||
| In accordance with Paragraph 8 of Schedule 2 of the Health and Social Care Act 2012 it is considered that it would not be in the public interest to permit press and public to attend this part of the meeting due to the nature of the business to be transacted. |
||||
Click here to download the glossary of commonly used terms.
